XML 124 R114.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
period
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
numberOfWarrants
Related Party Transaction [Line Items]          
Annual base management fee percentage     1.50%    
Base management fee to affiliate [1] $ 4,913 $ 3,990 $ 9,869 $ 8,256  
Base management fee, gross 5,000 4,600 10,200 9,500  
Management Fee Expense, Rebates 100 600 $ 283 1,261 [1]  
Incentive fee rate     25.00%    
Incentive fee hurdle rate fixed     9.00%    
Incentive fee hurdle rate floating     3.00%    
Minimum percentage of incentive fee to be paid in share     10.00%    
Termination Fee, Number Of Periods | period     2    
Termination Fee, Period     12 months    
Expense Reimbursement Period     60 days    
Expense Reimbursement - Manager     $ 9,000 6,000  
Real estate owned [2],[3] 21,076   21,076   $ 28,403
Securities, at fair value(1)(2) [2],[3] 1,500,863   1,500,863   1,459,465
Non-controlling interests [2] 22,099   22,099   24,919
Accrued expenses and other liabilities [2] 106,514   106,514   73,819
Reverse repurchase agreements 2,557,864   2,557,864   2,609,685
Other assets [2] 100,853   100,853   76,791
Unpaid Principal Balance 11,780,908   11,780,908   11,609,077
Related Party Transaction, Purchases from Related Party   3,900   5,000  
Securities Collateral relating to Reverse Repurchase Agreements 3,200,000   3,200,000   3,200,000
Income Tax Expense (Benefit) 83 (7,825) 104 (14,785)  
Loans, at fair value [2],[3] 11,822,695   11,822,695   11,626,008
Earnings (losses) from investments in unconsolidated entities (5,868) (23,265) (2,424) (28,771)  
Payments to Acquire Equity Method Investments     44,555 10,294  
Investment in unconsolidated entities, at fair value [2] 118,420   118,420   127,046
Realized gains (losses) on securities and loans, net (17,388) (18,830) (54,155) (18,025)  
Corporate loan [Member]          
Related Party Transaction [Line Items]          
Unpaid Principal Balance 6,568   6,568   4,132
Loans, at fair value 6,532   6,532   4,086
Related Party-Consumer Loans Titled in Name of Related Party          
Related Party Transaction [Line Items]          
Fair value of loans held in related party trust 77,200   77,200   70,200
Affiliated Entity [Member]          
Related Party Transaction [Line Items]          
Accounts payable and accrued expenses [2] 5,000   5,000   4,100
Mortgage Originator          
Related Party Transaction [Line Items]          
Warehouse facility, monetary amount $ 5,000   $ 5,000    
Interest rate 15.00%   15.00%    
Advances made under warehouse facility $ 0   $ 0   0
Purchasing Entity          
Related Party Transaction [Line Items]          
Fair value of loans held in related party trust 2,800   2,800   4,300
Related party trust - Residential Mortgage Loans and REO          
Related Party Transaction [Line Items]          
Fair value of loans held in related party trust 1,400,000   1,400,000   1,500,000
Jepson Holdings Limited          
Related Party Transaction [Line Items]          
Investment in unconsolidated entities, at fair value 700   700   $ 600
LendSure Mortgage Corp [Member]          
Related Party Transaction [Line Items]          
Earnings (losses) from investments in unconsolidated entities (1,600) $ (7,700) (3,100) $ (12,100)  
Promissory note to equity method investee, effective date November 2022 | Equity Method Investee | Corporate loan [Member]          
Related Party Transaction [Line Items]          
Investment Interest Rate         10.00%
Unpaid Principal Balance         $ 50
Loans, at fair value         50
Realized gains (losses) on securities and loans, net     (500)    
Commercial mortgage loans and REO          
Related Party Transaction [Line Items]          
Reverse repurchase agreements 236,600   236,600   274,400
Fair Value 5,500   5,500   2,200
Investment in Loan Originator | LendSure Mortgage Corp [Member]          
Related Party Transaction [Line Items]          
Investment in unconsolidated entities, at fair value 23,500   23,500   $ 26,700
Investment in Loan Originator | Loan Originator - Other          
Related Party Transaction [Line Items]          
Earnings (losses) from investments in unconsolidated entities     (100)    
Warrants | Mortgage Originator          
Related Party Transaction [Line Items]          
Derivative, Number of Instruments Held | numberOfWarrants         8,280,000
Long          
Related Party Transaction [Line Items]          
Securities, at fair value(1)(2) 1,500,863   1,500,863   $ 1,459,465
Warrants | Mortgage Originator          
Related Party Transaction [Line Items]          
Investment in unconsolidated entities, at fair value 10,200   10,200   11,500
Non-controlling interest of joint venture partner | Unrelated third party joint venture interest | Commercial mortgage loans and REO          
Related Party Transaction [Line Items]          
Non-controlling interests 900   900   300
Non-controlling interest of joint venture partner | Related party joint venture interest | Commercial mortgage loans and REO          
Related Party Transaction [Line Items]          
Non-controlling interests 1,400   1,400   400
Mortgage-related Commercial | Corporate equity securities          
Related Party Transaction [Line Items]          
Fair Value 62,600   62,600   68,500
Participation in multi-borrower financing facility          
Related Party Transaction [Line Items]          
Outstanding debt of related party 677,200   677,200   872,500
Warehouse facilities - CLO securitizations          
Related Party Transaction [Line Items]          
Investment in unconsolidated entities, at fair value $ 400   $ 400   $ 500
[1] See Note 15 for further details on management fee rebates.
[2] Ellington Financial Inc.'s Condensed Consolidated Balance Sheets include assets and liabilities of variable interest entities it has consolidated. See Note 11 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.
[3] Includes assets pledged as collateral to counterparties. See Note 13 for additional details on the Company's borrowings and related collateral.